From experimentation to the surgical treatment of Parkinson's disease: Prelude or suite in basal ganglia research?

Progress in Neurobiology

Volumn 59, Issue 5, 1999, Pages 509-532

  Gross, Christian E ^a   Boraud, Thomas ^a   Guehl, Dominique ^a   Bioulac, Bernard ^a   Bezard, Erwan ^a  

^a Basal Gang   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL GANGLION; BRAIN DEPTH STIMULATION; DYSKINESIA; HUMAN; NEUROSURGERY; NONHUMAN; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STEREOTAXIC SURGERY; THALAMOTOMY; TISSUE GRAFT;

ANIMALS; BASAL GANGLIA; HUMANS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0032801718     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00015-5     Document Type: Review

References (283)

1. Aebischer P., Tresco P.A., Winn S.R., Greene L.A., Jaeger C.B. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111:1991;269-275.
2. Agid Y., Javoy-Agid F., Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. Marsden C.D., Fahn S. Movement disorders II. 1987;166-200 Butterworths, London.
3. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L.D., Poenaru L., Perricaudet M., Kahn A., Peschanski M. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3:1993;224-228.
4. Albe-Fessard D., Arfel G., Guiot G. Activités électriques charactéristiques de quelques structures cérébrales chez l'homme. Ann. Chir. 17:1963;1185-1214.
5. Albe-Fessard D., Arfel G., Guiot G., Derome P., Hertzog E., Vourch G., Aleonard P. Electrophysiological studies of some deep cerebral structure in man. J. Neurol. Sci. 3:1966;37-51.
6. Albe-Fessard D., Arfel G., Guiot G., Derome P., Guilbaud G. Thalamic unit activity in man. Electroencephalogr. Clin. Neurophysiol. 25:1967;132-142.
7. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
8. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
9. Allen G.S., Burns R.S., Tulipan N.B., Parker R.A. Adrenal medullary transplantation into the caudate nucleus in Parkinson's disease: initial clinical results in 18 patients. Arch. Neurol. 46:1989;487-491.
10. Aluman J. Are neurons formed in the brains of adult mammals? Science. 135:1962;1127-1128.
11. Anderson M.A. The basal ganglia and movement. Towe A.L., Lushei E.S. Handbook of Behavioral Neurobiology: Motor Coordination. vol. 5:1981;367-399 Plenum Press, New York.
12. Anglade P., Blanchard V., Raisman-Vozari R., Faucheux B.A., Herrero M.T., Obeso J.A., Mouatt-Prigent A., Kastner A., Strada O., Javoy-Agid F., Agid Y., Hirsch E.C. Is dopaminergic cell death accompanied by concomitant nerve plasticity? Battistin L., Scarlato G., Caraceni T., Ruggieri S. Advances in Neurology. vol. 69:1996;195-208 Lippincott-Raven Publishers, Philadelphia.
13. Arai R., Karasawa N., Geffard M., Nagatsu I. L-dopa is converted to dopamine in serotonergic fibers of the striatum of the rat. A double-labelling immunofluorescence study. Neurosci. Lett. 195:1995;195-198.
14. Aziz T.Z., Peggs D., Sambrook M.A., Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord. 6:1991;288-292.
15. Backlund E.O., Granberg P.O., Hamberger B. Transplantation of adrenal medullary tissue to striatum in parkinsonism. J. Neurosurg. 62:1985;169-173.
16. Bankiewicz K.S., Plunkett R.J., Kopin I.J., Jacobowitz D.M., London W.T., Oldfield E.H. Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. Prog. Brain Res. 78:1988;543-549.
17. Bankiewicz K.S., Plunkett R.J., Jacobowitz D.M., Porrino L., DiPorzio U., London W.T., Kopin I.J., Oldfield E.H. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. J. Neurosurg. 72:1990;231-244.
18. Bankiewicz K.S., Leff S.E., Nagy D., Jungles S., Rokovitch J., Spratt K., Cohen L., Libonati M., Snyder R.O., Mandel R.J. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease. Exp. Neurol. 144:1997;147-156.
19. Barük H., Trotot M., Wolfin M. Psychochirurgie et neurochirurgie: à propos d'un cas de Parkinson postencephalitique avec hallucinations ayant subi la lobotomie. Rev. Neurol. 88:1953;191-196.
20. Bejjani B., Damier P., Arnulf I., Bonnet A.M., Vidailhet M., Dormont D., Pidoux B., Cornu P., Marsault C., Agid Y. Pallidal stimulation for Parkinson's disease: two targets? Neurology. 49:1997;1564-1569.
21. Benabid A.L., Pollak P., Louveau A., Henry S., DeRougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl. Neurophysiol. 50:1987;344-346.
22. Benabid A.L., Pollak P., Gervason C., Hoffmann D., Gao D.M., Hommel M., Perret J., DeRougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 337:1991;403-406.
23. Benabid A.L., Pollak P., Gao D., Hoffmann D., Limousin P., Gay E., Payen I., Benazzouz A. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J. Neurosurg. 84:1996;203-214.
24. Benazzouz A., Gross C., Féger J., Boraud T., Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5:1993;382-389.
25. Benazzouz A., Piallat B., Pollak P., Benabid A.L. Responses of substantial nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci. Lett. 189:1995;77-80.
26. Benazzouz A., Boraud T., Féger J., Burbaud P., Bioulac B., Gross C. Alleviation of experimental hemiparkinsonism by high frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Mov. Disord. 11:1996;627-632.
27. Bergman H., Wichmann T., Delong M.R. Reversal of experimental parkinsonism by lesion of the subthalamic nucleus. Science. 249:1990;1436-1438.
28. Bergman H., Feingold A., Nini A., Raz A., Slovin H., Abeles M., Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci. 21:1998;32-38.
29. Beric A., Sterio D., Dogali M., Fazzini E., Eidelberg D., Kolodny E. Characteristics of pallidal neuronal discharges in Parkinson's disease patients. Battisan L., Scarlato G., Caraceni T., Ruggieri S. Advances in Neurology. 1996;123-128 Lippincott-Raven Publishers, Philadelphia.
30. Bertrand C., Martinez S.N., Hardy J. Stereotactic surgery for parkinsonism. Prog. Neurol. Surg. 5:1973;79-112.
31. Betchereva N.P., Bondartchuk A.N., Smirnov V.M., Meliutcheva L.A., Shandurina A.N. Method of electrostimulation of the deep brain structures in treatment of some chronic diseases. Confin. Neurol. 37:1975;136-140.
32. Beurrier, C., Audin, J., Bioulac, B., 1996. An electrophysiological study of the subthalamic nucleus neurons in rat brain slice preparation, Paper presented at the Soc. Neurosci. Abstr., Washington.
33. Beurrier C., Bezard E., Bioulac B., Gross C.E. Subthalamic stimulation elicits hemiballismus in normal money. Neuroreport. 8:1997;1625-1629.
34. Beurrier C., Congar P., Bioulac B., Hammond C. Bistable membrane properties behavior of subthalamic nucleus neurons. J. Neurosci. 19:1999;599-609.
35. Bezard E., Gross C.E. Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Prog. Neurobiol. 55:1998;93-116.
36. Bilang-Bleuel A., Revah H., Colin P., Locquet I., Robert J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial cell-line derived neurotrophic factor prevents dopaminergic neuron degernation and behavioural impairment in a rat model of parkinson's disease. Proc. natl. Acad. Sci. USA. 94:1997;8818-8823.
37. Birkmayer W., Hornykiewicz O. Der L-Dopa Effekt bei der Parkinson-Akinese. Wien. klin. Wschr. 73:1961;787.
38. Birkmayer W., Hornykiewicz O. Der L-Dopa Effekt beim Parkinson-Syndrom des Menschen. Zur Pathogenese und Behandlung der Parkinson-Akinese. Arch. Psychiat. Nervenkr. 203:1962;560-574.
39. Björklnd A., Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
40. Björklund A., Stenevi U. Regeneration of monoaminergic and cholinergic neurons in the mammalian central nervous system. Physiol. Rev. 59:1979;62-100.
41. Björklund A., Stenevi U. Neural Grafting in the Mammalian CNS. 1985;Elsevier Science, Amsterdam.
42. Blanchard V., Anglade P., Dziewezapolski G., Savasta M., Agid Y., Raisman-Vozari R. Dopaminergic sprouting in the rat striatum after partial lesion of the SN. Brain Res. 709:1996;319-325.
43. Blandini F., Porter R.H.P., Greenamyre J.T. Glutamate and Parkinson's disease. Mol. Neurobiol. 12:1996;73-94.
44. Blond S., Caparros-Lefebvre D., Parker F., Assaker R., Petit H., Guieu J-D., Christiaens J-L. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J. Neurosurg. 77:1992;62-68.
45. Bohn M.C., Cupit L., Marciano F., Gash D.M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 237:1987;913-916.
46. Boraud T., Bezard E., Bioulac B., Gross C. High frequency stimulation of the internal globus pallidus reduces the higher firing frequency of its neuron in the MPTP-treated monkey model of Parkinson's disease. Neurosci. Lett. 215:1996;17-20.
47. Boraud T., Bezard E., Bioulac B., Gross C. Electrophysiological mapping of the pallidum in the normal monkey: frequency, pattern and relation to passive limb movements. Eur. J. Neurosci. 10:(suppl. 10):1998;301.
48. Boraud T., Bezard E., Guchl D., Bioulac B., Gross C. Effects of L-DOPA on neuronal activity of the Globus Pallidus externalis (GPe) and Globus Pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res. 787:1998;157-160.
49. Boraud, T., Bezard, E., Imbert, C., Bioulac, B., Gross, C., 1998c. Effect of different dopaminergic agonists on the activity of pallidal neurones in the normal monkey, Paper presented at the Soc. Neuroci. Abstr., Los Angeles.
50. Bravo G.J., Cooper I.S. A clinical and radiological correlation of the lesions produced by chemopallidectomy and thalamectomy. J. Neurol. Neurosurg. Psychiat. 22:1959;1-10.
51. Brotchie J.M., Mitchell I.J., Sambrook M.A., Crossman A.R. Alleviation of parkinsonism by antagonism of excitatory amino-acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord. 6:1991;133-138.
52. Browder Y. Section of the fibers to the anterior limb of the internal capsule in parkinsonism. Am. J. Surg. 75:1948;264-268.
53. Brundin P., Strecker R.E., Lindvall O., Isacson O., Nilsson O.G., Barbin G., Prochiantz A., Forni C., Nieoullon A., Widner H., Gage F.H., Björklund A. Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann. N.-Y. Acad. Sci. 495:1987;473-495.
54. Burbaud P., Gross C., Bioulac B. Effects of subthalamic high frequency stimulation on substantial nigra pars reticulata and globus pallidus neurons in normal rats. J. Physiol. 88:1994;3-4.
55. Burbaud P., Gross C., Benazzouz A., Coussemacq M., Bioulac B. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Exp. Brain Res. 105:1995;48-58.
56. Caparros-Lefebvre D., Blond S., Vermersch P., Pecheux N., Guieu J-D., Petit H. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J. Neurol. Neurosurg. Ps. 56:1993;268-273.
57. Caparros-Lefebvre D., Ruchoux M.M., Blond S., Petit H., Percheron G. Long-term thalamic stimulation in Parkinson's disease. Neurology. 44:1994;1856-1860.
58. Carvey P.M., Ptak L.R., Kao L., Cleanse H.L. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in culture of rostral mesencephalic tegmentum. Clin. Neuropharmac. 12:1989;425-434.
59. Cash R., Dennis T.L., Heureux R., Raisman R., Javoy-Agid F., Scatton B. Parkinson's disease and dementia. Norepinephrine and dopamine in locus coeruleus. Neurology. 37:1987;42-46.
60. Chang, J.W., Goldstein, M., Milstien, S., Kang, U.J., 1998. Mutated form of tyrosine hydroxylase reduces feedback inhibition by dopamine in genetically modified grafts implanted in parkinsonian rats, Paper presented at the Soc. Neurosci. Abstr., Los Angeles.
61. Clarke R.H. Investigations of the central nervous system. Methods and Instruments. 1920;1-162 John Hopkins Hospital Reports, Baltimore.
62. Cunningham L.A., Hansen J.T., Short M.P., Bohn M.C. The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res. 561:1991;192-202.
63. Date L., Felten S.Y., Felten D.L. The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft. Brain Res. 545:1991;191-198.
64. Davis K.D., Taub E., Houle S., Lang A.E., Dostrovsky J.O., Tasker R.R., Lozano A.M. Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nature Med. 3:1997;671-674.
65. Defer G., Geny C., Ricolfi F., Fenelon G., Monfort J.C., Remy P., Villafane G., Jeny R., Samson Y., Keravel Y., Gaston A., Degos J.D., Peschanski M., Cesaro P., N'Guyen J.P. Long-term outcome of unilaterally transplanted parkinsonian patients. I. clinical approach. Brain. 119:1996;41-50.
66. DeJong G.J., Meerwaldt J.D., Schmitz P.I.M. Factors that influence the occurrence of response variations in Parkinson's disease. Ann. Neurol. 21:1987;4-7.
67. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
68. DeLong M.R. Activity of pallidal neurons during movement. J. Neurophysiol. 34:1971;414-427.
69. DeLong M.R. Activity of basal ganglia neurons during movement. Brain Res. 40:1972;127-135.
70. Dogali M., Fazzini E., Kolodny E., Eidelberg D., Sterio D., Devinsky O., Beric A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology. 45:1995;753-761.
71. Dravid A., Jaton A.L., Enz A., Frei P. Spontaneous recovery from motor asymmetry in adult rats with 6-OHDA induced lesion of the SN. Brain Res. 311:1984;361-365.
72. Dunnett S.B. Towards a neural transplantation therapy for Parkinson's disease: experimental principles from animal studies. Acta Neurochir. 52:1991;35-38.
73. Dunnett S.B. Transplantation of embryonic dopamine neurons; what we know from rats. J. Neurol. 238:1991;65-74.
74. Dunnett S.B., Richards S-J. Neural transplantation. Prog. Brain Res. 85:1990;285-296.
75. During M.J., Naegele J.R., O'Malley K.L., Geller A.I. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
76. Ehringer H., Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschr. 38:1960;1236-1239.
77. Emerich D.F., Winn S.R., Christenson L., Palmatier M., Gentile F.T., Sanberg P.R. A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy. Neurosci. Biobehav. Rev. 16:1992;437-447.
78. Emerich D.F., Plone M., Francis J., Frydel B.R., Winn S.R., Lindner M.D. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblast. Brain Res. 736:1996;99-110.
79. Emerich D.F., Winn S.R., Hantraye P.M., Peschanski M., Chen E.Y., Chu Y., McDermott P., Baetge E.E., Kordower J.H. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature. 386:1997;395-399.
80. Fahn S., Elton R.L., Committee MotU.D. Unified Parkinson's Disease Rating Scale. Fahn S., Marsden C.D. Recent Developments in Parkinson's Disease. vol. 2:1987;153-164 Macmillan Health Care, Florham Park.
81. Fenelon F. Essais de traitement neurochirugical du syndrome parkinsonien par intervention directe sur les voies extrapyramidales immédiatement sous-striatopallidales. Rev. Neurol. 83:1950;437-440.
82. Fenelon F. Neurosurgery of ansa lenticularis in dyskinesias and Parkinson's disease: review of principles and techniques of a personal operation. Sem. Hop. Paris. 31:1955;1835.
83. Fiancada M.S., Kordower J.H., Hansen J.T., Jiao S.S., Gash D.M. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp. Neurol. 102:1988;76-91.
84. Filion M., Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;142-151.
85. Filion M., Tremblay L., Bédart P.J. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in Parkinson's disease. Brain Res. 444:1988;165-176.
86. Filion M., Tremblay L., Bédart P.J. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;152-161.
87. Fisher L.J., Jinnah H.A., Kale L.C., Higgins G.A., Gage F.H. Survival and function of intrastriatal grafted primary fibroblasts genetically modified to produce L-dopa. Neuron. 6:1991;371-380.
88. Foix C., Nicolesco J. L'anatomie pathologique de la maladie de Parkinson. 1925;Masson, Paris.
89. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J.X., Lone T., Zhang Y.B., Snyder J.A., Wells T.H. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327:1992;1549-1555.
90. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.H., Vingerhoets F.J. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
91. Frohna P.A., Neal-Beliveau B.S., Joyce J.N. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions. Synapse. 25:1997;293-305.
92. Frysinger, R.C., Negoro, K., Bronstein, J.M., Masterman, D., Mazziotta, J., Cohen, M., DeSalles, A., 1998. Estimation of lesion volumes in pallidotomy procedures: acute vs chronic volumes, Paper presented at the Soc. Neurosci. Abstr., Los Angeles.
93. Gao D., Benazzouz A., Piallat B., Bressard K., Ilinsky I.A., Kultasllinksy K., Benabid A.L. High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey. Neuroscience. 88:(1):1999;201-212.
94. Gash D.M., Zhang Z., Cass W.A., Ovadia A., Simmerman L., Martin D., Russell D., Collins F., Hoffer B.J., Gerhardt G.A. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J. Comp. Neurol. 363:1995;345-358.
95. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkey treated with GDNF. Nature. 380:1996;252-255.
96. Gill S.S., Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet. 350:1997;1224.
97. Gillingham F.J., Watson W.A.S., Donaldson A.A., Naughton J.A.L. The surgical treatment of parkinsonism. Br. Med. J. 2:1960;1395-1402.
98. Gnanalingham K.K., Milkowski N.A., Smith L.A., Hunter A.J., Jenner P., Marsden C.D. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Eur. J. Pharmac. 277:1995;235-241.
99. Goetz C.G. Dopaminergic agonists in the treatment of Parkinson's disease. Neurology. 46:1990;50-57.
100. Goetz C.G., Olanow C.W., Koller W.C., Penn R.D., Cahill D., Morantz R., Stebbins G., Tanner C.M., Klawans H.L., Shannon K.M. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N. Eng. J. Med. 320:1989;337-340.
101. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4:1984;2877-2890.
102. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4:1984;2866-2876.
103. Gros C., Vlahovitch B., Enjalbert J.M. Action des interventions préfrontales (leucotomie, topectomie) sur les manifestations psychiques et kinétiques des syndromes parkinsoniens. Sem. Hop. Paris. 31:1955;1831-1832.
104. Gross C., Rougier A., Guehl D., Boraud T., Julien T., Bioulac B. High frequency stimulation of the Globus Pallidus internalis in Parkinson's disease: a 7 case study. J. Neurosurg. 87:1997;491-498.
105. Guiot G., Brion S. Traitement neurochirurgical des syndromes choreo-athetosiques et parkinsonien. Sem. Hop. Paris. 49:1952;2095-2099.
106. Guiot G., Brion S. Traitement des mouvements anormaux par la coagulation pallidale. Technique et résultats. Rev. Neurol. 89:1953;578-580.
107. Guridi J., Lozano A.M. A brief history of pallidotomy. Neurosurgery. 41:1997;1169-1183.
108. Guridi J., Luquin M.R., Herrero M-T., Obeso J.A. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov. Disord. 8:1993;421-429.
109. Guridi J., Herrero M.T., Luquin M.R., Guillen J., Ruberg M., Laguna J., Vila M., Javoy-Agid F., Agid Y., Hirsch E., Obeso J.A. Subthalamotomy in parkinsonian monkeys: behavioural and biochemical analysis. Brain. 119:1996;1717-1727.
110. Hadjiconstantinou M., Rossetti M., Paxton R.C., Neff N.H. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Neuropharmacology. 25:1986;1075-1077.
111. Hadjiconstantinou M., Mariani A.P., Neff N.H. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Brain Res. 484:1989;297-303.
112. Halliday G.M., Li Y.W., Blumbergs P.C., Joh T.H., Cotton R.G.H., Howe P.R.C., Blessing W.W., Geffen L.B. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann. Neurol. 27:1990;373-385.
113. Hamada I., DeLong M.R. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J. Neurophysiol. 68:1992;1859-1866.
114. Hammond C., Féger J., Bioulac B., Souteyrand J.P. Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus Luysii. Brain Res. 171:1979;577-580.
115. Hansen J.T., Kordower J.H., Fiandaca M.S., Jiao S.S., Notter M.F., Gash D.M. Adrenal medullary autografts into the basal ganglia of cebus monkey: graft viability and fine structure. Exp. Neurol. 102:1988;65-75.
116. Hassler R. Zur Normal Anatomie der Substantial Nigra, Versuch einer architektonischen Gliederung. J. Physchol. Neurol. 48:1937;1-55.
117. Hassler R. Zur Pathologie der Paralysis Agitans und des postenzephalitischen Parkinsonismus. J. Psychol. Neurol. 48:1938;387-476.
118. Hassler R. Über die afferente Leitung und Steuerung des striären Systems. Nervenartz. 20:1949;537-541.
119. Hassler R. Die Anatomie des Thalamus. Arch. Psychiat. Nervenkr. 184:1950;249-256.
120. Hassler R., Riechert T., Mundinger F., Umbach W., Gangleberger J.A. Pysiological observations in stereotaxic operations in extrapyramidal motor disturbances. Brain. 83:1960;337-350.
121. Hassler R., Mundinger F., Riechert T. Correlations between clinical and autoptic findings in stereotaxic operations of parkinsonism. Confin. Neurol. (Basel). 26:1965;282-290.
122. Hassler R., Mundinger F., Riechert T. Pathophysiology of tremor at rest derived from the correlation of anatomical and clinical data. Confin. Neurol. (Basal). 32:1970;79-87.
123. Hassler R., Mundinger F., Riechert T. Stereotaxis in Parkinson Syndrome. 1979;Springer-Verlag, Berlin.
124. Hayase N., Filion M., Richard H., Boraud T. Electrical stimulation of the subthalamic nucleus in fully parkinsonian (MPTP) monkeys: effects of clinical signs and pallidal activity. Ohye C. The Basal Ganglia V. 1996;241-248 Plenum Press, New York.
125. Henderson B.T.H., Clough C.G., Hughes R.C., Hitchcock E.R., Kenny B.G. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch. Neurol. 48:1991;822-827.
126. Henderson J.M., Dunnett S.B. Targeting the subthalamic nucleus in the treatment of Parkinson's disease. Brain Res. Bull. 46:1998;467-474.
127. Herrero M.T., Perez-Otano I., Hirsch E.C., Agid Y., Luquin M.R., Obeso J.A., DelRio J. GM1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience. 56:1993;965-972.
128. Hirsch E.C., Duyckaerts C., Javoy-Agid F., Hauw J.J., Agid Y. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease? Ann. Neurol. 27:1990;676-682.
129. Horellou P., Mallet J. Gene therapy for Parkinson's disease. Mol. Neurobiol. 15:1997;241-256.
130. Horellou P., Brundin P., Kalen P., Mallet J., Bjorklund A. Behavioural effect of engineered cells that synthesize L-Dopa or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2:1990;116-119.
131. Horellou P., Brundin P., Kalen P., Mallet J., Bjorklund A. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron. 5:1990;393-402.
132. Horellou P., Lundberg C., LeBourdeles B., Wictorin K., Brundin P., Kalen P., Bjorklund A., Mallet J. Behavioural effects of genetically engineered cells releasing DOPA and dopamine after intracerebral grafting in a rat model of Parkinson's disease. J. Physiol. (Paris). 85:1991;158-170.
133. Horellou P., Vigne E., Castel M.N., Barnéoud P., Colin P., Perricaudet M., Delaere P., Mallet J. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport. 6:1994;49-53.
134. Hornykiewicz O. The mechanism of action of L-dopa in Parkinson's disease. Life Sci. 15:1974;1249-1259.
135. Horsley V. Remarks on the surgery of the central nervous system. Br. Med. J. 2:1890;1286-1292.
136. Horsley V., Clarke R.H. The structure and functions of the cerebellum examined by a new method. Brain. 31:1908;45-123.
137. Howells D.W., Donnan G.A., Wong J.Y.F., Kaczmarczyk S.J., Chilcho P.J., Fabinyi G.C., Mendelsohn F.A.O. Surgical damage stimulates proliferation of dopamine uptake sites in normal mouse brain. Brain Res. 622:1993;285-288.
138. Howells D.W., Liberatore G.T., Wong J.Y.F., Donnan G.A. Dopaminergic responses to striatal damage. J. Neurol. Sci. 139:1996;125-130.
139. Hubble J.P., Busenbark K.L., Wilkinson S., Penn R.D., Lyons K., Koller W.C. Deep brain stimulation for essential tremor. Neurology. 46:1996;1150-1153.
140. Hubble J.P., Busenbark K.L., Wilkinson S., Penn R.D., Lyons K., Koller W.C. Effect of thalamic deep brain stimulation based on tremor type and diagnosis. Mov. Disord. 12:(3):1997;337-341.
141. Hutchinson W.D., Lozano A.M., Davis K.D., Saint-Cyr J.A., Lang A.E., Dostrovsky J.O. Differential neuronal activity in segments of Globus Pallidus in Parkinson's disease patients. Neuroreport. 5:1994;1533-1537.
142. Hyman C., Hofer M., Barde Y-A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantial nigra. Nature. 350:1991;230-232.
143. Ikemoto K., Kitahama K., Jouvet A., Arai R., Nishimura A., Nishi K., Nagatsu I. Demonstration of L-dopa decarboxylating neurons specific to human striatum. Neurosci. Lett. 232:1997;111 - 114.
144. Isacson O., Deacon T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20:1997;477-482.
145. Janson, A.M., Zhao, M., 1997. Time course study of the total number of nesting immunoreactive cells in substantial nigra after an MPTP-induced lesion in C57/BL6 mouse, Paper presented at the Soc. Neurosci. Abstr., New Orleans.
146. Javoy-Agid F., Ruberg M., Pique L., Bertagna X., Taquet H., Studler J.M., Cesselin F., Epelbaum J., Agid Y. Biochemistry of the hypothalamus in Parkinson's disease. Neurology. 34:1984;672-675.
147. Jellinger K. Pathologic correlates of dementia in Parkinson's disease. Arch. Neurol. 44:1987;690.
148. Jonsson G., Gorio A., Hallman H., Kojima H., Janigro D., Luthman J., Zanoni R. Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins. J. Neurosci. Res. 12:1984;459-476.
149. Joyce J.N., Frohna P.S., Neal-Beliveau B.S. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci. Biobehav. Rev. 20:1996;453-486.
150. Kandel E.I. Functional and Stereotactic Neurosurgery. 1989;Plenum Medical Book, New York.
151. Kaneoke Y., Vitek J.L. Burst and oscillations as disparate neuronal properties. J. Neurosci. Meth. 68:1996;211-223.
152. Kaplan M.S. Plasticity after brain lesions: contemporary concepts. Arch. Phys. Med. Rehabil. 69:1988;984-991.
153. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8:1994;148-154.
154. Kingdom PsD.R.GitU. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Br. Med. J. 307:1993;469-472.
155. Kingdom PsD.R.GitU. Comparisons of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Br. Med. J. 311:1995;1602-1607.
156. Kitaiï S.T., Kita H. Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. Carpenter M.B., Jayaraman A. Basal Ganglia II. vol. 32:1987;357-573 Plenum Press, New York.
157. Klemme R.M. Surgical treatment of dystonia, paralysis agitans and athetosis. Arch. Neurol. Psychiatry. 44:1940;926.
158. Kordower J.H., Felten D.L., Gash D.M. Neural grafting for Parkinson's disease. Olanow C.W., Lieberman A.N. The Scientific Basis for the Treatment of Parkinson's Disease. 1992;175-224 Parthenon Publishing, Park Ridge.
159. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1995;1118-1124.
160. Kordower J.H., Liu Y-T., Winn S.R., Emerich D.F. Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical and neurochemical analysis. Cell. Trans. 4:1995;55-171.
161. Kordower J.H., Freeman T.B., Chen E-Y., Mufson E.J., Sanberg P.R., Hauser R.A., Snow B., Olanow C.W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13:1998;383-393.
162. Kordower J.H., Freeman T.B., Olanow C.W. Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Mov. Disord. 13:1998;88-95.
163. Krack P., Pollak P., Limousin P., Hoffman D., Benazzouz A., Benabid A.L. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain. 121:1998;451-457.
164. Kraus J.K., Jankovic J., Lai E.C., Rettig G.M., Grossman R.G. Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism. Arch. Neurol. 54:1997;1026-1029.
165. Laitinen L.V. Thalamic targets in the stereotaxic treatment of Parkinson's disease. J. Neurosurg. 24:1966;82-85.
166. Laitinen L.V., Bergenheim A.T., Hariz M.I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg. 76:1992;53-61.
167. Lapchak P.A., Miller P.J., Jiao S., Araujo D.M., Hilt D., Collins F. Biology of glial cell line-derived neurotrophic factor (GDNF): Implications for the use of GDNF to treat Parkinson's disease. Neurodegeneration. 5:1996;197-205.
168. Lees A.J. Levodopa substitution: the gold standard. Clin. Neuropharmac. 17:1994;S1-S6.
169. Lees G.J. Therapeutic potential of AMPA receptor ligand in neurological disorders. CNS Drugs. 5:1996;51-74.
170. Lees G.J., Stern G.M. Sustained low-dose levodopa therapy in Parkinson's disease: a 3-year follow-up. Adv. Neurol. 37:1983;9-15.
171. LeGallaSalle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M., Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
172. Lesser R.P., Fahn S., Snider S.R., Cote L.J., Isgreen W.P., Barrett R.E. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 19:1979;1253-1260.
173. Liberatore G.T., Wong J.Y.F., Porritt M.J., Donnan G.A., Howells D.W. Expression of glial cell line-derived neurotrophic factor (GDNF) mRNA following mechanical injury to mouse striatum. Neuroreport. 8:1997;3097-3101.
174. Lieberman A.N., Goldstein M. Bromocriptine in Parkinson's disease. Pharmac. Rev. 37:1985;217-227.
175. Limousin P. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
176. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Broussole E., Perret J.E., Benabid A.L. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov. Disord. 10:1995;672-674.
177. Limousin P., Pollak P., Hoffmann D., Benazzouz A., Perret J.E., Benabid A.L. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov. Disord. 11:1996;231-235.
178. Limousin P., Greene J., Pollak P., Rothwell J., Benabid A.L., Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal
179. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
180. Lindvall O. Update on fetal transplantation: the Swedish experience. Mov. Disord. 13:1998;83-87.
181. Lindvall O., Backlund E.O., Farde L. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann. Neurol. 22:1987;457-468.
182. Lindvall O., Rehncrona S., Brundin P., Gustavii B., Astedt B., Widner H., Lindholm T., Bjorklund A., Leenders K.L., Rothwell J.C. Human fetal dopamine neurons grafted into the striatum in two patients with Parkinson's disease: a detailed account of methodology and 6 month follow-up. Arch. Neurol. 46:1989;615-631.
183. Lindvall O., Rehncrona S., Gustavii B., Brundin P., Astedt B., Widner H., Lindholm T., Bjorklund A., Leenders K.L., Rothwell J.C. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet. 1:1988;1483-1484.
184. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;575-577.
185. Ling, Z.D., Carvey, P.M., 1997. Mesencephalic progenitor cells exposed to cytokines become enriched in dopamine neurons, Paper presented at the Soc. Neurosci. Abstr., New Orleans.
186. Lozano A.M., Lang A.E. Pallidotomy for Parkinson's disease. Neurosurg. Clin. 9:1998;325-336.
187. Lozano A.M., Lang A.E., Galvez-Jimenez N., Miyasaky J., Duff J., Hutchinson W.D., Dostrovsky J.O. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 346:1995;1383-1387.
188. Lozano A., Hutchinson W., Kiss Z., Tasker R., Davis K., Dostrovsky J. Methods for microelectrode-guided posteroventral pallidotomy. J. Neurosurg. 84:1996;194-202.
189. Lundberg C., Martinez-Serrano A., Cattaneo E., McKay R.D.G., Björklund A. Survival, integration and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp. Neurol. 145:1997;342-360.
190. Madrazo I., Drucker-Colin R., Daiz V., Martinez-Mata J., Torres C., Becerril J.J. Adrenal medulla transplanted to caudate nucleus for treatment of Parkinson's disease: report of 10 cases. Surg. Forum. 38:1987;510-511.
191. Madrazo I., Drucker-Colin R., Daiz V., Martinez-Mata J., Torres C., Becerril J.J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316:1987;831-834.
192. Madrazo I., Leon V., Torres C., Aguilera M.C., Varela G., Alvarez F., Fraga A., Drucker-Colin R., Ostrosky F., Skurovich M. Transplantation of fetal substantial nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N. Engl. J. Med. 318:1988;51.
193. Mahalik T.J., Finger T.E., Stromberg I., Olson L. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft-host interconnections. J. Comp. Neurol. 240:1985;60-70.
194. Mallet J., Blanot F., Boni C., Dumas S., Faucon-Biguet N., Grima B., Horellou P., Julien J.F., Kahn P., Lamouroux A. A molecular genetic approach to the study of catecholamine. Biochem. Soc. Trans. 15:1987;126-128.
195. Marsden C.D., Parkes J.D., Quinn N. Fluctuations of disability in Parkinson's disease - clinical aspects. Marsden C.D., Fahn S. Movement Disorders. 1982;96-122 Butterworths, London.
196. Martin D., Miller G., Cullen T., Fisher N., Dix D., Russell D. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behaviour in rats. Eur. J. Pharmac. 317:1996;247-256.
197. McLellan D.L. Cerebellar and deep brain stimulation in movement disorders. Marsden C.D., Fahn S. Movement Disorders. 1982;334-344 Butterworth, London.
198. Mehta V., Spears J., Mendez I. Neural transplantation in Parkinson's disease. Can. J. Neurol. Sci. 24:1997;292-301.
199. Melamed E., Hefti F., Wurtman R.J. Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann. Neurol. 8:1980;558-563.
200. Meyers H.R. Surgical procedures for postencephalitic tremor with notes of the physiology of the premotor fibers. Arch. Neurol. Psychiat. 44:1940;455-461.
201. Meyers H.R. The modifications of alternating tremors, rigidity and festination by surgery of the basal ganglia. Res. Publ. Assoc. Nerv. Ment. Dis. 21:1942;602-665.
202. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50:1996;381-425.
203. Mirenowicz J., Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature. 379:1996;449-451.
204. Miyawaki E., Lyons K., Pahwa R., Tröster A.I., Hubble J., Smith D., Busenbark K., McGuire D., Michalek D., Koller W.C. Motor complications of chronic levodopa therapy in parkinson's disease. Clin. Neuropharmac. 20:1997;523-530.
205. Mundinger F. Stereotaxic interventions on the zona incerta for treatment of extrapyramidal motor disturbances and their results. Confin. Neurol. 26:1965;222-230.
206. Narabayashi H. Surgical approach to tremor. Marsden C.D., Fahn S. Movement Disorder. 1982;292-299 Butterworth, London.
207. Narabayashi H. Tremor mechanisms. Schaltenbrand G., Walker A.E. Stereotaxy of the Human Brain. 1982;510-514 Thieme Verlag, Stuttgart.
208. Narabayashi H. Stereotaxic Vim thalamotomy for treatment of tremor. Eur. Neurol. 29:(suppl. 1):1989;29-32.
209. Narabayashi H., Okuma T. Procaine oil blocking of the globus pallidus for treatment of rigidity and tremor of parkinsonism: preliminary report. Proc. Jpn Acad. 29:1953;134.
210. Nashold B.S., Slaughter D.G. Some observations on tremors. Gillingham F.J. Third Symposium on Parkinson's disease. 1969;241-246 Livingstone, New York.
211. Obeso J.A., Linazasoro G., Rothwell J.C., Jahanshahi M., Brown R. Assessing the effects of pallidotomy in Parkinson's disease. Lancet. 347:1996;1490.
212. Obeso J.A., Alvarez L.M., Macias R.J., Guridi J., Teijeiro J., Juncos J.L., Rodriguez M.C., Ramos E., Linazasoro G.J., Gorospe A., DeLong M.R. Lesion of the subthalamic nucleus in Parkinson's disease. Neurology. 48:(suppl. 2):1997;A138.
213. Obeso J.A., Rodriguez M.C., Gorospe A., Guridi J., Alvarez L., Macias R. Surgical treatment of Parkinson's disease. Baill. Clin. Neurol. 6:1997;125-145.
214. Ohye C., Maeda T., Narabayashi H. Physiologically defined Vim nucleus. Its special reference to control of tremor. Appl. Neurophysiol. 39:1977;285-295.
215. Ohye C., Hirai T., Miyazaki M., Shibazaki T., Nakajima H. Vim thalamotomy for the treatment of various kinds of tremor. Appl. Neurophysiol. 45:1982;275-280.
216. Olanow C.W. A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease. Mov. Disord. 8:1993;81-87.
217. Olanow C.W., Koller W.C., Goetz C.G., et al. Autologous transplantation of adrenal medulla in Parkinson's disease: 18 month results. Arch. Neurol. 47:1990;1286-1289.
218. Onn S-P., Berger T.W., Stricker E.M., Zigmond M.J. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res. 376:1986;8-19.
219. Otto D., Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostratial system of MPTP-treated mice. J. Neurosci. 10:1990;1912-1921.
220. Pahwa R., Wilkinson S., Smith D., Lyons K., Miyawaki E., Koller W.C. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology. 49:1997;249-253.
221. Parent A., Hazrati L-N. Anatomical aspects of information processing in primate basal ganglia. Trends Neurosci. 16:1993;111-116.
222. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20:1995;91-127.
223. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20:1995;128-154.
224. Parkinson J. An Essay on the Shaking Palsy. 1817;Sherwood, Nelly and Jones, London.
225. Penit-Soria J., Durand C., Hervé D., Besson M-J. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats. Neuroscience. 77:1997;753-766.
226. Périer, C., Vila, M., Féger, J., Ruberg, M., Agid, Y., Hirsch, E.C., 1998. Functional activity of zona incerta neurons is altered after nigro-striatal denervation in rats, Paper presented at the Soc. Neurosci. Abstr., Los Angeles.
227. Perlow M.J., Freed W.J., Hoffer B.J., Seiger A., Olson L., Wyatt R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostratial dopamine system. Science. 204:1979;643-647.
228. Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., Geny C., Samson Y., Hantraye P., Jeny R., Gaston A., Keravel Y., Degos J.D., Cesaro P. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain. 117:1994;487-499.
229. Peterson D.I., Price M.L., Small C.S. Autopsy findings in a patient who had adrenal to brain transplant for Parkinson's disease. Neurology. 39:1989;235-238.
230. Piallat B., Benazzouz A., Benabid A.L. Subthalamic nucleus lesion in rats prevents dopamigergic nigral neuron degeneration after striatal 6-OHDA injection: behavioral and immunohistochemical studies. Eur. J. Neurosci. 8:1996;1408-1414.
231. Plunkett R.J., Bankiewicz K.S., Cummings A.C., Miletich R.S., Schwartz J.P., Oldfield E.H. Evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone. J. Neurosurg. 73:1990;918-926.
232. Pollak P., Benabid A.L., Gross C., Gao D.M., Laurent A., Benazzouz A., Hoffmann D., Gentil M., Perret J. Effets de la stimulation du noyau sous-thalamique dans la maladie de Parkinson. Rev. Neurol. 149:1993;175-176.
233. Pollak P., Benabid A.L., Limousin P., Benazzouz A., Hoffmann D., LeBas J-F., Perret J. Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients. Battistin L., Scarlato T., Caraceni T., Ruggieri S. Advances in Neurology. vol. 69:1996;591-594 Lippincott-Raven Publishers, Philadelphia.
234. Przedborski S., Levivier M., Kostic V., Jackson-Lewis V., Dollison A., Gash D.M., Fahn S., Cadet J.L. Sham transplantation protects 6-OHDA-induced dopaminergic toxicity in rats: behavioural and morphological evidence. Brain Res. 550:1991;231-238.
235. Rajput A.H., Stern W., Laverty W.H. Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology. 34:1984;991-996.
236. Raymon H.K., Thode S., Gage F.H. Application of ex vivo gene therapy in the treatment of Parkinson's disease. Exp. Neurol. 144:1997;82-91.
237. Riechert T. Stereotaxic operations for extrapyramidal motor disturbances with particular regards to age groups. Confin. Neurol. 26:1966;213-217.
238. Riechert T. Stereotaxic surgery fro treatment of Parkinson's syndrome. Prog. Neurol. Surg. 5:1973;1-78.
239. Ruottinen H.M., Rinne U.K. Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa-related fluctuations. J. Neurol. Neurosurg. Psy. 60:1996;36-40.
240. Schneider J.S., Pope A., Simpson K., Taggart J., Smith M.G., DiStefano L. Recovery from experimental Parkinsonism in primates with GM1 ganglioside treatment. Science. 256:1992;843-846.
241. Scott R.M., Brody J.A., Cooper I.S. The effect of thalamotomy on the progress of unilateral Parkinson's disease. J. Neurosurg. 32:1970;286-288.
242. Siegfried J. Neurosurgical treatment of Parkinson's disease. present indications and value. Rinne U.K., Klinger M., Staum G. Parkinson's Disease: Current Progress, Problems and Management. 1980;369-376 Elsevier, Amsterdam.
243. Siegfried J., Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery. 35:1994;1126-1130.
244. Siegfried J., Wellis G. Chronic electrostimulation of ventroposterolateral pallidum: follow-up. Acta Neurochir. 68:1997;11-13.
245. Sladek J.R., Gash D.M. Neural Transplants, Development, Plasticity, and Function. 1984;Plenum Press, New York.
246. Song, W.J., Otsuka, T., Baba, Y., Murakami, F., 1997. Characterization of Ca2+ currents in acutely isolated rat subthalamic nucleus neurones, Paper presented at the Soc. Neurosci. Abstr., New Orleans.
247. Song, W.J., Otsuka, T., Murakami, F., 1998. Hyperpolarization changes the firing mode of rat subthalamic nucleus neurons by enabling generation of a plateau potential, Paper presented at the Soc. Neurosci. Abstr., Los Angeles.
248. Spatz M. Physiologies des Zentralnervensystems der WirbelTiere. 1927;Springer, Berlin.
249. Spencer D.D., Robbins R.J., Naftolin F., Marek K.L., Vollmer T., Leranth C., Roth R.H., Price L.H., Gjedde A., Bunney B.S. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327:1992;1541-1548.
250. Spiegel E.A. Development of stereoencephalotomy for extrapyramidal diseases. J. Neurosurg. 24:1966;433-439.
251. Spiegel E.A., Wycis H.T. Stereoencephalotomy. Part I. Methods and Stereotaxic Atlas of Human Brain. 1952;Grune and Stratton, New York.
252. Spiegel E.A., Wycis H.T. Pallido-ansotomy: anatomic-physiological foundation and histopathologic control. Field W.S. Pathogenesis and Treatment of Parkinsonism. 1958;88-105 Charles C Thomas, Springfield.
253. Spiegel E.A., Wycis H.T. Campotomy in various extrapyramidal disorders. J. Neurosurg. 20:1963;871-884.
254. Spiegel E.A., Wycis H.T., Marks M., Lee A.J. Stereotaxic apparatus for operations on the human brain. Science. 106:1947;349-350.
255. 2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse. 19:1995;264-293.
256. Starr P.A., Vitek J.L., Bakay R.A.E. Ablative surgery and deep brain stimulation for Parkinson's disease. Neurosurgery. 43:(5):1998;989-1013.
257. Stenevi U., Björklund A. Transplantation techniques for the study of regeneration in the central nervous system. Prog. Brain Res. 48:1978;101-112.
258. Stenevi U., Björklund A., Svengaard N.A. Transplantation of central and peripheral monoamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res. 114:1976;1-20.
259. Sterio D., Beric A., Dogali M., Fazzini E., Alfaro G., Devinsky O. Characteristics of pallidal neuronal discharges in Parkinson's disease patients. Ann. Neurol. 35:1994;586-591.
260. Strada O., Hirsch E.C., Javoy-Agid F., Duyckaerts C., Hauw J.J., Agid Y. Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease. J. Neurol Sci. 120:1993;33-37.
261. Strömberg L., Herrera-Marschitz M., Hultgren L., Ungerstedt U., Olson L. Adrenal medullary implants in the dopamine-denervated rat striatum I. Acute catecholamine levels in grafts and host caudate as determined by HPLC-electrochemistry and fluorescence histochemical image analysis. Brain Res. 297:1984;41-51.
262. Sutton J.P., Couldwell W., Lew M.F., Mallory L., Grafton S., DeGiorgio C., Welsh M., Apuzzo M.L.J., Ahmadi J., Waters C.H. Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery. 36:1995;1112-1117.
263. Svennilson E., Torvik A., Lowe R., Leksell L. Treatment of parkinsonism by stereotaxic thermolesions in the pallidal region. Acta Psychiat. Neurol. Scand. 35:1960;358-377.
264. Taha J.M., Favre J., Baumann T.K., Burchiel K.J. Characteristics and somatotopic organization of kinesthetic cells in the globus pallidus of patients with Parkinson's disease. J. Neurosurg. 85:1996;1005-1012.
265. Taha J.M., Favre J., Baumann T.K., Burchiel K.J. Tremor control after pallidotomy in patients with Parkinson's disease: correlation with microrecording findings. J. Neurosurg. 86:1997;642-647.
266. Talairach J., Hecaen H., David M., Monnies M., Ajuriaguerra J. Recherches sur la coagulation thérapeutique des structures sous corticales chez l'homme. Rev. Neurol. 81:1949;4-24.
267. Tasker R.R. Deep brain stimulation and thalamotomy for tremor compared. Acta Neurochir. (Wien). 68:1997;49-53.
268. Tasker R.R. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg. Neurol. 49:(2):1998;145-153.
269. Toffano G., Savoini G., Moroni F., Lombardi G., Calza L., Agnati L.F. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Brain Res. 261:1983;163-166.
270. Tomac A., Lindqvist E., Lin L.F.H., Ögren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-341.
271. Velasco F., Molina-Negro P., Bertrand C., Hardy J. Further definition of the subthalamic target for arrest of tremor. J. Neurosurg. 36:1972;184-191.
272. Vitek J.L., Bakay R.A.E. The role of pallidotomy in Parkinson's disease and dystonia. Curr. Opin. Neurol. 10:1997;332-339.
273. Vitek J.L., Bakay R.A.E., Hashimoto T., Kaneoke Y., Mewes K., Zhang J.Y., Rye D., Starr P., Baron M., Turner R., DeLong M.R. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J. Neurosurg. 88:1998;1027-1043.
274. Waters C., Itabashi H.H., Apuzzo M.L., Weiner L.P. Adrenal to caudate transplantation - postmortem study. Mov. Disord. 5:1990;248-250.
275. Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavi B., Hagell P., Jahanshahi M., Sanle G., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:1997;95-107.
276. Wichmann T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6:1996;751-758.
277. Widner H., Tetrud J., Rehncrona S., Snow B., Brundin P., Gustavii B., Bjorklund A., Lindvall O., Langston J.W. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1992;1556-1563.
278. Winn S.R., Tresco P.A., Zielinski B., Greene L.A., Jaeger C.B., Aebischer P. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113:1991;322-329.
279. Wolff J.A., Fisher L.J., Xu L., Jinnah H.A., Langlais P.J., Iuvone P.M., O'Malley K.L., Rosenberg M.B., Shimohama S., Friedmann T., Gage F.H. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease. Proc. natl Acad. Sci. USA. 86:1989;9011-9014.
280. Yahr M.D., Duvoisin R.C., Hoehn M.M., Schear M.J., Barrett R.E. L-dopa: its clinical effects in parkinsonism. Trans. Am. Neurol. Assoc. 93:1968;56-63.
281. Yoshimoto Y., Lin Q., Collier T.J., Frim D.M., Breakefield X.O., Bohn M.C. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691:1995;25-36.
282. Zigmond M.J., Stricker E.M. Adaptive properties of monoaminergic neurons. Lajtha A. Handbook of Neurochemistry. vol. 9:1985;87-102 Plenum Press, New York.
283. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 13:1990;290-296.